Vol. 2 No. 9 (2025), Articles
Vol. 2 No. 9 (2025)

KRIPTORXIZM KELIB CHIQISH SABABLARI

Articles
Published 2025-05-29
Abdukarimov. J. Sh.
Toshkent Pediatriya Tibbiyot Instituti “Tibbiy biologiya” fakulteti 4-bosqich talabasi, Toshkent Pediatriya Tibbiyot Instituti “Urologiya, Bolalar urologiya” kafedrasi
Xaltursunov. D.Sh.
Ilmiy rahbar-Assistant
PDF

Keywords

Kriptorxizm, moyak tushmasligi, tug‘ma anomaliya, gormonal nomutanosiblik, genetik omillar, atrof-muhit ta’siri, embrional rivojlanish, bepushtlik, jarrohlik davolash, gormonal terapiya.

Abstract

Kriptorxizm – bu moyaklarning tuxumdon xaltasiga tushmasligi bilan tavsiflanadigan tug‘ma patologik holat. Bu kasallik asosan embrional rivojlanish jarayonidagi buzilishlar, genetik omillar, gormonal nomutanosiblik va atrof-muhit ta’sirlari natijasida yuzaga keladi. Kriptorxizm tashxisi ultratovush tekshiruvi va fizik tekshiruv asosida qo‘yiladi. Davolash usullari orasida gormonal terapiya va jarrohlik aralashuvi mavjud bo‘lib, erta tashxis qo‘yish va davolash bepushtlik, moyak o‘smalari kabi asoratlarning oldini olishga yordam beradi.

PDF

References

[1] Hutson, J. M., Thorup, J., & Beasley, S. W. (2016). "Disorders of the Testes and Scrotum and Their Surgical Management." Springer.

[2] Barthold, J. S., & González, R. (2019). "The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy." The Journal of Urology, 202(2), 275-283.

[3] Clarnette, T. D., & Hutson, J. M. (2017). "Testicular position and fertility potential." British Journal of Urology International, 120(6), 856-863.

[4] Kollin, C., & Granholm, T. (2020). "Cryptorchidism and fertility: current evidence and future perspectives." Acta Paediatrica, 109(4), 678-685.

[5] Нажмутдинова, Д., Урунбаева, Д., Садыкова, Н., Артыкова, Д., & Кудратова, Н. (2014). Современные возможности инсулинотерапии сахарного диабета 2 типа. Журнал вестник врача, 1(4), 27-29.

[6] Radmayr, C., Dogan, H. S., Silay, M. S., et al. (2019). "EAU Guidelines on Paediatric Urology: Management of Undescended Testes." European Urology, 76(6), 760-773.

[7] Main, K. M., Toppari, J., Suomi, A. M., & Kaleva, M. (2017). "Environmental endocrine disruptors and cryptorchidism." Molecular and Cellular Endocrinology, 445, 1-9.

[8] Шагазатова, Б. Х., & Мирхайдарова, Ф. С. (2019). ФАКТОРЫ РИСКА И ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ САХАРНОГО ДИАБЕТА 2 ТИПА У ВИЧ-ИНФИЦИРОВАННЫХ БОЛЬНЫХ. In Российская наука в современном мире (pp. 24-25).

[9] Acerini, C. L., Rich, S. A., Ong, K. K., & Dunger, D. B. (2018). "Fetal and maternal influences on cryptorchidism: A life course epidemiology approach." The Lancet Endocrinology & Metabolism, 6(7), 545-556.

[10] Cortes, D., Müller, J., & Skakkebæk, N. E. (2017). "Cryptorchidism and testicular pathology: A clinical and histological study." The Journal of Clinical Endocrinology & Metabolism, 102(5), 1896-1904.